Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Respiratory Medicine|January 20, 1999
Early reversibility to salbutamol does not always predict bronchodilation after salmeterol in stable chronic obstructive pulmonary diseaseM Cazzola, A Vinciguerra, F Di Perna, et al.
Pulmonary Pharmacology & Therapeutics|September 29, 1999
Incremental benefit of adding oxitropium bromide to formoterol in patients with stable COPDM Cazzola, F Di Perna, C Califano, et al.
Minerva Anestesiologica|March 5, 2004
Tranexamic acid in primary CABG surgery: high vs low doseG Armellin, A Vinciguerra, R Bonato, et al.
Biomaterials|October 1, 1982
Corrosion of the Harrington's instrumentation and biological behaviour of the rod-human spine systemL Aulisa, A di Benedetto, A Vinciguerra, et al.
Journal of Chemotherapy (Florence, Italy)|February 1, 1995
Evaluation of the effects of pefloxacin on platelet aggregation in vitro and ex vivo in patients suffering from chronic bronchitisM Cazzola, G Santangelo, M Angrisani, et al.
L'Encephale|October 14, 2018
[Personality profiles of students at risk of dropping out: Resilients, Overcontrollers and Undercontrollers]A Vinciguerra, C Réveillère, C Potard, et al.
Respiratory Medicine|May 1, 1995
Salmeterol and formoterol in partially reversible severe chronic obstructive pulmonary disease: a dose-response studyM Cazzola, M G Matera, G Santangelo, et al.
Journal of Biological Regulators and Homeostatic Agents|January 8, 2021
Palatal prosthetic rehabilitation in patients affected by cocaine-induced midline destructive lesionsM Trimarchi, A Rampi, A Vinciguerra, et al.
International Journal of Clinical Pharmacology and Therapeutics|February 1, 1994
Evaluation of lung tissue and hilar lymph node concentrations of azithromycinM Cazzola, C Siniscalchi, A Vinciguerra, et al.
Minerva Medica|April 30, 1998
[Correlation between pulmonary pharmacokinetics and pharmacodynamics support the hypothesis of the usefulness of ceftazidime at a single 1g daily dose in the treatment of bacterial exacerbation of chronic obstructive bronchopneumonia with moderate functional damage]M Cazzola, P Noschese, A Vinciguerra, et al.
Pageof 4